Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148665258> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2148665258 endingPage "67" @default.
- W2148665258 startingPage "67" @default.
- W2148665258 abstract "To determine the efficacy and safety of treating predominantly hemorrhagic age-related macular degeneration (AMD) with transconjunctival sutureless vitrectomy (TSV), tissue plasminogen activator (tPA), sulphur hexafluoride (SF6), and intravitreal bevacizumab.Retrospective study, consecutive case series. Patients with acute hemorrhagic AMD treated with 25- or 23-gauge TSV, subretinal or intravitreal tPA, fluid-air-SF6 exchange and intravitreal injection of bevacizumab. All operations were performed within the first 5 days after the start of symptoms, which consisted of visual acuity (VA) loss and central scotoma.Fifteen eyes from 15 patients were included. The patients' mean age was 79.6 years, and the mean follow-up was 11.8 months. Five patients (33%) were receiving oral anticoagulant treatment. At baseline, the mean VA (logMAR values) was 1.5 (20/640 Snellen equivalent). At the last follow-up visit, the mean VA was 1.1 (20/250) (P < 0.0001; paired t-test). The submacular hemorrhage was successfully displaced in all the cases. Complications consisted of three cases of vitreous hemorrhage and a tear or the retinal pigment epithelium. Twelve cases (80%) did not require further treatment during the follow-up period.A surgical approach with 25- or 23-gauge TSV, tPA, SF6 and intravitreal bevacizumab is an efficacious and safe procedure in patients with hemorrhagic AMD. Early treatment is advisable for obtaining the optimal outcome." @default.
- W2148665258 created "2016-06-24" @default.
- W2148665258 creator A5061301452 @default.
- W2148665258 creator A5075601330 @default.
- W2148665258 date "2010-02-01" @default.
- W2148665258 modified "2023-10-17" @default.
- W2148665258 title "Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration" @default.
- W2148665258 cites W176826057 @default.
- W2148665258 cites W1969426112 @default.
- W2148665258 cites W1969982263 @default.
- W2148665258 cites W1973188041 @default.
- W2148665258 cites W1987813682 @default.
- W2148665258 cites W2018732055 @default.
- W2148665258 cites W2025150761 @default.
- W2148665258 cites W2059705096 @default.
- W2148665258 cites W2085107422 @default.
- W2148665258 cites W2113555556 @default.
- W2148665258 cites W2124415048 @default.
- W2148665258 cites W2126480394 @default.
- W2148665258 cites W2136348784 @default.
- W2148665258 cites W2137354143 @default.
- W2148665258 cites W2050414454 @default.
- W2148665258 doi "https://doi.org/10.2147/opth.s8635" @default.
- W2148665258 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2827187" @default.
- W2148665258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20186279" @default.
- W2148665258 hasPublicationYear "2010" @default.
- W2148665258 type Work @default.
- W2148665258 sameAs 2148665258 @default.
- W2148665258 citedByCount "35" @default.
- W2148665258 countsByYear W21486652582012 @default.
- W2148665258 countsByYear W21486652582014 @default.
- W2148665258 countsByYear W21486652582015 @default.
- W2148665258 countsByYear W21486652582016 @default.
- W2148665258 countsByYear W21486652582017 @default.
- W2148665258 countsByYear W21486652582018 @default.
- W2148665258 countsByYear W21486652582019 @default.
- W2148665258 countsByYear W21486652582020 @default.
- W2148665258 countsByYear W21486652582021 @default.
- W2148665258 countsByYear W21486652582022 @default.
- W2148665258 countsByYear W21486652582023 @default.
- W2148665258 crossrefType "journal-article" @default.
- W2148665258 hasAuthorship W2148665258A5061301452 @default.
- W2148665258 hasAuthorship W2148665258A5075601330 @default.
- W2148665258 hasBestOaLocation W21486652581 @default.
- W2148665258 hasConcept C118487528 @default.
- W2148665258 hasConcept C126322002 @default.
- W2148665258 hasConcept C141071460 @default.
- W2148665258 hasConcept C2776403814 @default.
- W2148665258 hasConcept C2776572282 @default.
- W2148665258 hasConcept C2776694085 @default.
- W2148665258 hasConcept C2777802072 @default.
- W2148665258 hasConcept C2778257484 @default.
- W2148665258 hasConcept C2781242345 @default.
- W2148665258 hasConcept C71924100 @default.
- W2148665258 hasConceptScore W2148665258C118487528 @default.
- W2148665258 hasConceptScore W2148665258C126322002 @default.
- W2148665258 hasConceptScore W2148665258C141071460 @default.
- W2148665258 hasConceptScore W2148665258C2776403814 @default.
- W2148665258 hasConceptScore W2148665258C2776572282 @default.
- W2148665258 hasConceptScore W2148665258C2776694085 @default.
- W2148665258 hasConceptScore W2148665258C2777802072 @default.
- W2148665258 hasConceptScore W2148665258C2778257484 @default.
- W2148665258 hasConceptScore W2148665258C2781242345 @default.
- W2148665258 hasConceptScore W2148665258C71924100 @default.
- W2148665258 hasLocation W21486652581 @default.
- W2148665258 hasLocation W21486652582 @default.
- W2148665258 hasLocation W21486652583 @default.
- W2148665258 hasLocation W21486652584 @default.
- W2148665258 hasLocation W21486652585 @default.
- W2148665258 hasOpenAccess W2148665258 @default.
- W2148665258 hasPrimaryLocation W21486652581 @default.
- W2148665258 hasRelatedWork W1970554379 @default.
- W2148665258 hasRelatedWork W1988039871 @default.
- W2148665258 hasRelatedWork W1993747607 @default.
- W2148665258 hasRelatedWork W1995044506 @default.
- W2148665258 hasRelatedWork W2010362076 @default.
- W2148665258 hasRelatedWork W2042956061 @default.
- W2148665258 hasRelatedWork W2314067402 @default.
- W2148665258 hasRelatedWork W2352532362 @default.
- W2148665258 hasRelatedWork W3131056513 @default.
- W2148665258 hasRelatedWork W2599281049 @default.
- W2148665258 isParatext "false" @default.
- W2148665258 isRetracted "false" @default.
- W2148665258 magId "2148665258" @default.
- W2148665258 workType "article" @default.